Genedata Launches First Genomic Analysis Platform for Beer, Wine, and Spirits Producers

First-in-class Genedata Selector for Beer, Wine & Spirits manages and analyzes genomic profiling data to optimize production processes

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Genedata Selector for Beer, Wine & Spirits will be an ideal solution for enhancing yeast breeding and fermentation strategies.

Basel, Switzerland (PRWEB) June 04, 2012

Genedata, a leading provider of advanced software solutions for life science, biotech, and drug discovery research, today announced release of the new Genedata Selector™ for Beer, Wine & Spirits. This first-in-class turnkey solution provides a platform for comprehensive genomic data analysis of brewing yeast and other genomes vital to improving the efficiency of fermentation processes. It enables researchers to optimize production strains and develop testing tools that monitor product quality, yeast viability, genetic drift, and microbial purity. Genedata Selector for Beer, Wine & Spirits includes pre-processed, “gold standard” genome data from beer and wine yeast strains, as well as plants and industry-specific microbes.

“Genedata Selector for Beer, Wine & Spirits will be an ideal solution for enhancing yeast breeding and fermentation strategies,” noted Prof. Hiroshi Takagi of the Nara Institute of Science and Technology. “Its ability to integrate a variety of complex experimental data from omics studies and securely store intellectual property as it applies to patents will be highly valuable for applied microbiologists like me.”

Beyond a Genomic Database
On a single platform, Genedata Selector for Beer, Wine & Spirits uniquely provides an integrated and relational view into genome sequences as well as the foundation for comparative genomics and mutation analysis. It relates any type of molecular data from sequences over pathways to phenotypes and intellectual property, enabling efficient phenotype-genotype analysis across the R&D pipeline. Capitalizing on the vast amount of data generated by new molecular technologies such as next-generation sequencing, transcriptomics, proteomics, and metabolomics, the Beer, Wine & Spirits edition helps identify variations in yeast physiology to effectively improve production processes and quality management.

As part of the Genedata Selector family of industry-specific editions, the Beer, Wine & Spirits edition is open, enterprise-level, and scalable. Supporting innovative research, it gives researchers, technical brewers, and quality controllers the ability to analyze their experimental data in a fully integrated fashion. When coupled with proprietary data, Genedata Selector for Beer, Wine & Spirits provides a comprehensive platform that fuels discovery and strengthens intellectual property by delivering genomic insights into:

  • Catalysts: Improve knowledge of genetics and physiology of yeast strains under fermentation for enhanced process efficiency and product quality.
  • Ingredients: Understand biology at the molecular level to identify advantageous traits in plant mutants that can be transferred to new high yield varieties.
  • Quality Management: Investigate and monitor microbial purity to produce premium quality beer and alcoholic beverages.

“Genedata is committed to supporting industrial biotechnology with innovations that make R&D and production processes more efficient,” said Dr. Othmar Pfannes, CEO of Genedata. “With the Genedata Selector for Beer, Wine & Spirits edition, we provide a tailor-made, computational solution that addresses specific requirements of the beverage industry. Of equal importance, we enrich our state-of-the-art software with a portfolio of domain-focused professional, consulting, and hosting services for a complete one-stop solution.”

Available directly from Genedata, Genedata Selector for Beer, Wine & Spirits can be hosted by Genedata or installed locally.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery, industrial biotechnology, and life science research. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata solutions make research data accessible and understandable, enabling scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Japan, Germany, and the US. http://www.genedata.com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.


Contact